Involvement of apoptosis in mitomycin C hypersensitivity of Chinese hamster cell mutants
E Papouli1, C Lafon, A Valette
1Institut de Pharmacologie et de Biologie Structurale, UPR 9062, C.N. R.S., 31077, Toulouse, France.
Abstract:
To elucidate the mechanisms of the mammalian cell defense against cross-linking agents, we studied previously cellular responses to mitomycin C (MMC) treatment in two MMC-hypersensitive hamster cell mutants' V-H4 and V-C8, as well as their parental cell line V79. In the present report, we investigated whether alterations in cell cycle checkpoints and induction of apoptosis could be responsible for the MMC hypersensitivity of the V-H4 and V-C8 mutant cell lines. First, we found that parental and mutant cells exhibited similar cell cycle responses to MMC concentrations of equivalent cytotoxicity, arguing against a defective cell cycle checkpoint in hypersensitive cell lines. In contrast, we showed that mutant cells underwent greater levels of apoptosis following MMC treatment than parental cells. These findings indicate that increased induction of apoptosis contributes to the hypersensitivity of V-H4 and V-C8 cells to the growth inhibitory effect of MMC. This differential apoptotic response was observed with both equimolar and equitoxic MMC doses and was specific to the cross-linking agent MMC, suggesting that control of the apoptotic process is altered in both MMC-hypersensitive mutants. The defective genes in V-H4 and V-C8 cells would then function in the regulation of an apoptotic pathway triggered by MMC-induced damage and independent of p53-mediated transcription.
Insights
Mutant hamster cells show increased apoptosis when treated with mitomycin C (MMC), contributing to their hypersensitivity. This suggests altered regulation of the apoptotic pathway, independent of p53.
Area of Science:
- Cell Biology
- Genetics
- Molecular Toxicology
Background:
- Mammalian cells possess defense mechanisms against DNA cross-linking agents like mitomycin C (MMC).
- MMC-hypersensitive hamster cell mutants (V-H4, V-C8) and their parental V79 cells were used to study cellular responses.
- Understanding hypersensitivity mechanisms is crucial for cancer therapy and toxicology.
Purpose of the Study:
- To investigate if altered cell cycle checkpoints or apoptosis induction cause MMC hypersensitivity in V-H4 and V-C8 cells.
- To determine the specific role of apoptosis in the growth inhibitory effects of MMC.
Main Methods:
- Comparative analysis of cell cycle progression in parental and mutant cells following MMC treatment.
- Quantification of apoptosis levels in response to equimolar and equitoxic MMC doses.
- Assessment of MMC specificity on the apoptotic pathway.
Main Results:
- Parental and mutant cells displayed similar cell cycle responses to cytotoxic MMC concentrations.
- V-H4 and V-C8 mutant cells exhibited significantly higher levels of apoptosis compared to parental cells after MMC exposure.
- The increased apoptosis was specific to the cross-linking agent MMC.
Conclusions:
- Defective cell cycle checkpoints do not explain the MMC hypersensitivity of V-H4 and V-C8 cells.
- Increased apoptosis induction is a key factor contributing to MMC hypersensitivity in these mutants.
- The findings suggest a defect in the regulation of an MMC-induced apoptotic pathway, independent of p53-mediated transcription.
Related Concept Videos
Abnormal Proliferation
Cellular Injury V: Apoptosis and Autophagy
The Intrinsic Apoptotic Pathway


